Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Stefano Piaserico and Francesco Messina.
Stefano Piaserico
Connection Strength
3.200
Francesco Messina
  1. Correspondence on 'Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept. A report on a patient with COVID-19 with psoriatic arthritis receiving ustekinumab'. Ann Rheum Dis. 2021 05; 80(5):e79.
    View in: PubMed
    Score: 0.898
  2. REPLY TO: Interleukin-17: a potential therapeutic target in COVID-19. J Infect. 2020 09; 81(3):e37-e38.
    View in: PubMed
    Score: 0.890
  3. SARS-CoV-2 infection in a psoriatic patient treated with IL-23 inhibitor. J Eur Acad Dermatol Venereol. 2020 Jun; 34(6):e254-e255.
    View in: PubMed
    Score: 0.886
  4. Managing Psoriasis in Patients with HBV or HCV Infection: Practical Considerations. Am J Clin Dermatol. 2019 Dec; 20(6):829-845.
    View in: PubMed
    Score: 0.214
  5. Osteoporotic vertebral fracture caused by topical corticosteroid abuse: A case report. Exp Ther Med. 2019 Oct; 18(4):2746-2748.
    View in: PubMed
    Score: 0.209
  6. Secukinumab demonstrates improvements in absolute and relative psoriasis area severity indices in moderate-to-severe plaque psoriasis: results from a European, multicentric, retrospective, real-world study. J Dermatolog Treat. 2020 Aug; 31(5):476-483.
    View in: PubMed
    Score: 0.053
  7. Secukinumab drug survival in patients with psoriasis: A multicenter, real-world, retrospective study. J Am Acad Dermatol. 2019 07; 81(1):273-275.
    View in: PubMed
    Score: 0.051
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.